Kristine Wiencke

  • Head physician
  • +47 23 07 06 46

Publications 2016

Eskeland SL, Brunborg C, Seip B, Wiencke K, Hovde Ø, Owen T, Skogestad E, Huppertz-Hauss G, Halvorsen FA, Garborg K, Aabakken L, de Lange T (2016)
First quality score for referral letters in gastroenterology-a validation study
BMJ Open, 6 (10), e012835
DOI 10.1136/bmjopen-2016-012835, PubMed 27855107

Publications 2013

Schjesvold F, Wiencke K, Tjønnfjord GE (2013)
[Investigation of anemia]
Tidsskr Nor Laegeforen, 133 (6), 610
DOI 10.4045/tidsskr.13.0256, PubMed 23552139

Publications 2011

Wiencke K, Boberg KM (2011)
Current consensus on the management of primary sclerosing cholangitis
Clin Res Hepatol Gastroenterol, 35 (12), 786-91
DOI 10.1016/j.clinre.2011.04.007, PubMed 21963085

Publications 2007

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A (2007)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes
Tissue Antigens, 69 (2), 161-9
DOI 10.1111/j.1399-0039.2006.00738.x, PubMed 17257319

Publications 2006

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM (2006)
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis
Am J Gastroenterol, 102 (1), 115-21
DOI 10.1111/j.1572-0241.2006.00928.x, PubMed 17100974

Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
Scand J Gastroenterol, 41 (5), 586-91
DOI 10.1080/00365520500377870, PubMed 16638702

Publications 2005

Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
J Neuroimmunol, 166 (1-2), 197-201
DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527

Publications 2004

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group (2004)
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J Hepatol, 41 (2), 209-14
DOI 10.1016/j.jhep.2004.04.024, PubMed 15288468

Publications 2003

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease
Scand J Gastroenterol, 38 (3), 320-7
DOI 10.1080/00365520310000681, PubMed 12737449

Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E (2003)
Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease
Scand J Gastroenterol, 38 (3), 320-327
DOI 10.1080/00365520310000681, PubMed 28248598

Etokebe GE, Wiencke K, Haug T, Spurkland A (2003)
The use of modified primer competitors to enhance yields and specificity of HLA class I amplification by polymerase chain reaction (PCR)
Tissue Antigens, 61 (2), 172-6
DOI 10.1034/j.1399-0039.2003.00011.x, PubMed 12694586

Publications 2001

Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001)
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles
Hepatology, 34 (4 Pt 1), 625-30
DOI 10.1053/jhep.2001.27543, PubMed 11584356

Apr 28, 2016 Page visits: 1553